Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06993155Phase 2Recruiting
A Phase 2 trial of leflutrozole in oligozoospermia, Hypogonadism, sponsored by ReproNovo. Started Jun 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06993155.